Clinvest Research

Clinvest is a research organization dedicated to the advancement of medicine and health management through clinical research. Founded by Dr. Roger Cady in 1997, Clinvest began as a research office associated with a small, independent Primary Care and Headache Specialty Clinic located in Springfield Missouri. Dr. Cady's vision was to explore concepts sparked by information gathered in the clinic setting. Combining his clinical expertise in headache and his understanding of the value of patient reporting, both Clinvest Research Management and Clinvest Clinical Researchwere formed. The results of many those early migraine trials have revolutionized our understanding and the treatment of migraine today. Clinvest began with a small staff that included Dr. Cady and two nurses, who served both the clinic and research. That small staff expanded into a team of research professionals that includes in-house and satellite investigators who represent a wide range of specialties, certified nurse coordinators, research and lab assistants, and a data manager. We have nearly a century of combined research experience. Clinvest Research Management conducts and manages multi-center medical research with primary care providers throughout the United States. Projects include Phase III and Phase IV trials, surveys, and practice-related health outcome studies sponsored or funded by private industry and government agencies. Clinvest Clinical Research conducts FDA Phase II-IV research at our centrally-located, state of the art facility. Our dedicated team of Research Professionals is committed to excellence, making us one of the leaders in the field of Clinical Research. Clinvest Clinical Research has conducted more than 250 clinical trials sponsored by leading global pharmaceutical companies in a number of research areas including headache, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimer's disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory bio-markers, and hyperlipidemia.